ADC Therapeutics Reports Q2 2026 Results, Reassesses ZYNLONTA Path
at www.tipranks.com (Thu, 13-Aug 9:49 AM)
ADC Therapeutics Non-GAAP EPS of -$0.11, revenue of $19.25M beats by $0.35M
at seekingalpha.com (Thu, 13-Aug 7:45 AM)
ADC Therapeutics Q2 Earnings Preview
at seekingalpha.com (Wed, 12-Aug 3:06 PM)
